|
Oncology
|
Infectious Diseases
|
CNS/Pain
|
Respiratory
|
Internal Medicine
Maximising Opportunities Overcoming Challenges Drug development in many areas of internal medicine is thriving, with companies expanding their pipelines in metabolic, auto-immune, or kidney diseases. Various rare but devastating conditions have also moved into the focus of the industry, with a number of orphan drugs rapidly progressing through the stages of development, challenging the current clinical and regulatory paradigms. At TranScrip we are helping our biotech and pharma clients seize opportunities, address challenges and succeed in realising their drug development or lifecycle management goals by continually adapting and adopting new effective ways to achieve them.
Internal Medicine Medicine Internal
|